As on Wednesday, Century Therapeutics Inc (NASDAQ: IPSC) got off with the flyer as it spiked 44.44% to $1.3, before settling in for the price of $0.9 at the close. Taking a more long-term approach, IPSC posted a 52-week range of $0.34-$1.18.
It was noted that the giant of the Healthcare sector posted annual sales growth of 18.46% over the last 5 years. Meanwhile, its Annual Earning per share during the time was 18.46%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 91.72%. This publicly-traded company’s shares outstanding now amounts to $86.53 million, simultaneously with a float of $45.80 million. The organization now has a market capitalization sitting at $113.62 million. At the time of writing, stock’s 50-day Moving Average stood at $0.6642, while the 200-day Moving Average is $0.5711.
Century Therapeutics Inc (IPSC) Ownership Facts and Figures
Another important factor to analyze is how key investors are playing towards the stock of the Biotechnology industry. Century Therapeutics Inc’s current insider ownership accounts for 47.60%, in contrast to 28.16% institutional ownership. According to the most recent insider trade that took place on Dec 22 ’25, this organization’s Chief Scientific Officer bought 58,060 shares at the rate of 0.85, making the entire transaction reach 49,252 in total value, affecting insider ownership by 1,045,087. Preceding that transaction, on Dec 12 ’25, Company’s President and CEO bought 52,000 for 0.58, making the whole transaction’s value amount to 30,352. This particular insider is now the holder of 3,322,990 in total.
Century Therapeutics Inc (IPSC) Earnings and Revenue Records
Century Therapeutics Inc’s EPS increase for this current 12-month fiscal period is 91.72% and is forecasted to reach -0.85 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 20.63% through the next 5 years, which can be compared against the 18.46% growth it accomplished over the previous five years trading on the market.
Century Therapeutics Inc (NASDAQ: IPSC) Trading Performance Indicators
Let’s observe the current performance indicators for Century Therapeutics Inc (IPSC). It’s Quick Ratio in the last reported quarter now stands at 6.25. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 1.00.
In the same vein, IPSC’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.31, a figure that is expected to reach -0.27 in the next quarter, and analysts are predicting that it will be -0.85 at the market close of one year from today.
Technical Analysis of Century Therapeutics Inc (IPSC)
Through scrutinizing the latest numbers posted by the [Century Therapeutics Inc, IPSC], it can be observed that its last 5-days Average volume of 1.99 million was lower the volume of 2.37 million, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 64.16% While, its Average True Range was 79.18.
Raw Stochastic average of Century Therapeutics Inc (IPSC) in the period of the previous 100 days is set at 95.58%, which indicates a major rise in contrast to 94.36% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.1457 that was higher than 0.0509 volatility it exhibited in the past 100-days period.
